Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Operating Margin (2018 - 2026)

Updated

Regenerative Medical Technology (RMTG) recorded Operating Margin of 14.07% in Q2 2026, up 39.50 percentage points from -25.43% a year earlier and up 5.36 percentage points from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Operating Margin (2018 - 2026) Analysis & Trends

On a TTM basis, Regenerative Medical Technology's Operating Margin came in at 0.46% as of Jun 30, 2026, down 5.42 percentage points year-over-year; for FY2025, it came in at -17.00%, down 18.98 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +797.09 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at 1.98% in FY2024 (+31.65 pp), -29.68% in FY2023 (+47.75 pp), -77.43% in FY2022 (+2187.89 pp) and -2265.32% in FY2021 (-1451.23 pp).
  • The Q2 2026 figure is the highest quarterly Operating Margin since Q4 2024.
  • On a year-over-year basis, Operating Margin rose in five of the last eight quarters, with an average year-over-year change of +4.87 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 5418.52 percentage points in Q3 2022, against a drop of 5066.37 percentage points in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at 8.71% (Q1 2026), -19.48% (Q4 2025) and -37.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 14.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.07%
Mar 31, 2026 8.71%
Dec 31, 2025 -19.48%
Sep 30, 2025 -37.76%
Jun 30, 2025 -25.43%
Mar 31, 2025 9.89%
Dec 31, 2024 25.19%
Sep 30, 2024 1.99%
Jun 30, 2024 -26.97%
Mar 31, 2024 -12.86%
Dec 31, 2023 -21.95%
Sep 30, 2023 -11.60%
Jun 30, 2023 -119.23%
Mar 31, 2023 -9.44%
Dec 31, 2022 -20.34%
Sep 30, 2022 -43.97%
Jun 30, 2022 -122.89%
Mar 31, 2022 -181.55%
Dec 31, 2021 -196.56%
Sep 30, 2021 -5,462.49%
API Access

Regenerative Medical Technology Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEY